文献速递临床试验与 GCP基础与转化研究

渐进性运动对比最佳实践建议联合或不联合皮质类固醇注射治疗肩袖疾病(GRASP):多中心实用型2×2析因随机对照试验

Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial.
PubMed 文献 · Lancet · 2021-07-12

该实用型多中心2×2析因随机对照试验纳入708例肩袖疾病成人患者,比较渐进性运动与单次最佳实践建议联合或不联合皮质类固醇注射的疗效。结论:渐进性运动不优于单次最佳实践建议,肩峰下皮质类固醇注射无长期获益。

要点

  • 渐进性运动不优于单次物理治疗最佳实践建议。
  • 肩峰下皮质类固醇注射无长期获益。
  • 12个月内未报告严重不良事件。

核心结论

  • 渐进性运动在改善肩袖疾病患者肩痛和功能方面不优于单次最佳实践建议。
  • 肩峰下皮质类固醇注射对肩袖疾病患者无长期获益。

研究设计与样本

  • 实用型、多中心、优效性、2×2析因随机对照试验,从20个英国国家健康服务体系信托机构招募患者。
  • 纳入18岁及以上、过去6个月内新发肩袖疾病患者,排除显著肩部创伤史、影响肩部的神经疾病、其他肩部疾病、过去6个月内接受过皮质类固醇注射或物理治疗、或考虑手术者。
  • 采用中心化计算机生成系统按1:1:1:1随机分配至渐进性运动(≤6次)、最佳实践建议(1次)、皮质类固醇注射后渐进性运动、或皮质类固醇注射后最佳实践建议。
  • 共筛查2287例患者,随机分配708例:渐进性运动组174例、最佳实践建议组174例、皮质类固醇注射后渐进性运动组182例、皮质类固醇注射后最佳实践建议组178例。
  • 主要结局为12个月内肩痛和功能障碍指数(SPADI)评分,按意向性治疗分析,统计学显著性设定为1%。

主要发现

  • 12个月内SPADI数据可得率:渐进性运动组166例(95%)、最佳实践建议组164例(94%)、皮质类固醇注射后渐进性运动组177例(97%)、皮质类固醇注射后最佳实践建议组175例(98%)。
  • 未报告严重不良事件。

临床怎么用

  • 对于肩袖疾病患者,单次物理治疗最佳实践建议可作为渐进性运动的替代方案。
  • 不应期望肩峰下皮质类固醇注射带来长期改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticosteroid injections and physiotherapy exercise programmes are commonly used to treat rotator cuff disorders but the treatments' effectiveness is uncertain. We aimed to compare the clinical effectiveness and cost-effectiveness of a progressive exercise programme with a single session of best practice physiotherapy advice, with or without corticosteroid injection, in adults with a rotator cuff disorder. METHODS: In this pragmatic, multicentre, superiority, randomised controlled trial (2 × 2 factorial), we recruited patients from 20 UK National Health Service trusts. We included patients aged 18 years or older with a rotator cuff disorder (new episode within the past 6 months). Patients were excluded if they had a history of significant shoulder trauma (eg, dislocation, fracture, or full-thickness tear requiring surgery), neurological disease affecting the shoulder, other shoulder conditions (eg, inflammatory arthritis, frozen shoulder, or glenohumeral joint instability), received corticosteroid injection or physiotherapy for shoulder pain in the past 6 months, or were being considered for surgery. Patients were randomly assigned (centralised computer-generated system, 1:1:1:1) to progressive exercise (≤6 sessions), best practice advice (one session), corticosteroid injection then progressive exercise, or corticosteroid injection then best practice advice. The primary outcome was the Shoulder Pain and Disability Index (SPADI) score over 12 months, analysed on an intention-to-treat basis (statistical significance set at 1%). The trial was registered with the International Standard Randomised Controlled Trial Register, ISRCTN16539266, and EuDRACT, 2016-002991-28. FINDINGS: Between March 10, 2017, and May 2, 2019, we screened 2287 patients. 708 patients were randomly assigned to progressive exercise (n=174), best practice advice (n=174), corticosteroid injection then progressive exercise (n=182), or corticosteroid injection then best practice advice (n=178). Over 12 months, SPADI data were available for 166 (95%) patients in the progressive exercise group, 164 (94%) in the best practice advice group, 177 (97%) in the corticosteroid injection then progressive exercise group, and 175 (98%) in the corticosteroid injection then best practice advice group. We found no evidence of a difference in SPADI score between progressive exercise and best practice advice when analysed over 12 months (adjusted mean difference -0·66 [99% CI -4·52 to 3·20]). We also found no evidence of a difference between corticosteroid injection compared with no injection when analysed over 12 months (-1·11 [-4·47 to 2·26]). No serious adverse events were reported. INTERPRETATION: Progressive exercise was not superior to a best practice advice session with a physiotherapist in improving shoulder pain and function. Subacromial corticosteroid injection provided no long-term benefit in patients with rotator cuff disorders. FUNDING: UK National Institute for Health Research Technology Assessment Programme.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Hopewell S, Keene DJ, Marian IR, et al. Progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of patients with rotator cuff disorders (GRASP): a multicentre, pragmatic, 2 × 2 factorial, randomised controlled trial. Lancet. 2021. PMID: 34265255. doi:10.1016/S0140-6736(21)00846-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。